Abstract
Dear Editor,
We have reviewed the article titled “Early Use of Teriparatide in Preventing Surgical Intervention for Osteoporotic Vertebral Compression Fractures.” 1 This study investigates the potential benefits of early teriparatide treatment in preventing surgery among OVCF patients, offering valuable insights. We commend the authors for their contribution and provide constructive suggestions.
Firstly, while the article includes patient age, gender, and BMI, it lacks comprehensive background information regarding basic health status, comorbidities, and lifestyle factors (eg, alcohol consumption, diet). These variables could impact study outcomes significantly, necessitating thorough documentation in future research. 2
Secondly, the article did not comprehensively evaluate quality of life and functional outcomes. While VAS and ODI scores assess pain and functional impairment, comprehensive evaluations such as SF-36 for quality of life and daily living activity assessments were absent. These metrics are essential for understanding treatment effectiveness thoroughly, 3 and I recommend their inclusion in future studies.
Thirdly, addressing potential confounding factors is crucial. The article lacks clarification on controlling variables such as age, and baseline health status. To improve result accuracy, I suggest conducting multivariable regression analysis in future studies.
Lastly, ensuring data meet statistical assumptions (eg, normality, homogeneity of variance) is essential. The article mentions using t-tests without specifying if normality and homogeneity of variance tests were performed. If assumptions are not met, non-parametric tests (eg, Mann-Whitney U test) may be more suitable. I recommend conducting these tests and selecting appropriate statistical methods accordingly in future research.
In conclusion, while the article offers valuable insights into early teriparatide treatment for OVCF, there are opportunities to enhance statistical methods, control for confounding factors, and provide detailed patient background information. We believe these suggestions will bolster scientific rigor and thoroughness in future research efforts, anticipating more comprehensive follow-up studies.
